Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (20)

2024

  1. The incidence of HIV-2 infection in Spain is declining – a registry data analysis

    International Journal of Infectious Diseases, Vol. 146

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  2. HTLV-1-associated myelopathy in Spain

    Journal of Clinical Virology, Vol. 169

  3. Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain

    Alimentary Pharmacology and Therapeutics, Vol. 57, Núm. 5, pp. 540-548

  4. Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain

    Journal of Clinical Virology, Vol. 167

2022

  1. Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies

    Journal of Viral Hepatitis, Vol. 29, Núm. 9, pp. 777-784

  2. Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies: on behalf of the Human T-lymphotropic Virus (HTLV) Spanish Network

    International Journal of Infectious Diseases, Vol. 122, pp. 970-975

  3. Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain

    Hepatology International, Vol. 16, Núm. 5, pp. 1161-1169

2021

  1. Hepatitis delta in patients hospitalized in Spain (1997-2018)

    AIDS (London, England), Vol. 35, Núm. 14, pp. 2311-2318

2019

  1. Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 5, pp. 1357-1362

  2. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2

2017

  1. Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088

  2. HIV type 2 epidemic in Spain: Challenges and missing opportunities

    AIDS, Vol. 31, Núm. 10, pp. 1353-1364

  3. Human T-lymphotropic virus type 1 infection and disease in Spain

    AIDS, Vol. 31, Núm. 12, pp. 1653-1663

2015

  1. Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5

  2. Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5

2014

  1. HIV-2 and HTLV-1 infections in Spain, a non-endemic region

    AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159

  2. HIV-2 viral tropism influences CD4+ T cell count regardless of viral load

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194

  3. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

    AIDS, Vol. 28, Núm. 16, pp. 2461-2473

2007

  1. Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children

    BMC Infectious Diseases, Vol. 7